Stay updated on Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Sign up to get notified when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.

Latest updates to the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision changed from v3.3.1 to v3.3.2; this is a metadata update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedPublication source wording was clarified to indicate that publications are automatically filled from PubMed and the revision version was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study location entry changed from 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 736'.SummaryDifference0.1%

- Check46 days agoChange DetectedTwo screenshots show essentially identical page content and layout; no additions or deletions detected in the study details page.SummaryDifference0.2%

- Check68 days agoChange DetectedRegional rebranding: 'Rhône-Alpes' locations are replaced with 'Auvergne-Rhône-Alpes' equivalents, updating the area qualifier for the listed towns.SummaryDifference4%

- Check76 days agoChange Detected- Added a new version label (v3.2.0). - Removed the resource entry for small cell lung carcinoma under Genetic and Rare Diseases Information Center (GARD).SummaryDifference0.3%

Stay in the know with updates to Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.